NIKA PHARMACEUTICALS, INC (President, CEO, CFO) reported 2 transactions at NIKA PHARMACEUTICALS, INC
Review the transaction codes below to understand the nature of each event.
Filed: 3/19/2024ACC: 0001826466-24-000035
DirectorOfficer10% Owner· President, CEO, CFO
Since Apr 2022
+150M
Net shares
Net buyer
$250.00B
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
150M acquired
Non-Derivative Transactions2
Common
Indirect
Shares
+5M
Price / share
$50K
Trade value
$250B
% of position
New position
4/29/2022
0.00→5M
Common
Indirect
Shares
+145M
Price / share
—
Trade value
—
% of position
New position
7/20/2022
-145M→N/A
Total
Net shares
+150M
Net value
$250B
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Indirect | 4/29/2022 | J · J | +5M | $50K | $250B | New position | 0.00 | 5M |
| Common Indirect | 7/20/2022 | J · J | +145M | — | — | New position | -145M | N/A |
| Total | +150M | $250B | ||||||
Derivative Transactions0
No derivative transactions reported